Baseline Staging of Melanoma with Unknown Primary Site: The Value of Serum S100 Protein and Positron Emission Tomography

Publisher： Karger

E-ISSN： 1421-9832|217|4|351-355

ISSN： 1018-8665

Source： Dermatology, Vol.217, Iss.4, 2008-09, pp. : 351-355

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Appraisal of 18-Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging

By  

Dermatology, Vol. 200, Iss. 2, 2000-04 ,pp. : 167-169

Karger

Access to resources Recommend Favorite

Unknown Primary Melanoma: Worldwide Survey on Clinical Management

By  

Dermatology, Vol. 232, Iss. 6, 2017-01 ,pp. : 704-707

Karger

Access to resources Recommend Favorite

Detection of Melanoma Relapse: First Comparative Analysis on Imaging Techniques versus S100 Protein

By  

Dermatology, Vol. 213, Iss. 3, 2006-10 ,pp. : 187-191

Karger

Access to resources Recommend Favorite

Cutaneous Metastasis of Neuroendocrine Carcinoma with Unknown Primary Site: Case Report and Review of the Literature

By  

Case Reports in Dermatology, Vol. 7, Iss. 3, 2015-0 ,pp. : 263-274

Karger

Access to resources Recommend Favorite

S-100B and FDG-PET/CT in Therapy Response Assessment of Melanoma Patients

By  

Dermatology, Vol. 215, Iss. 3, 2007-09 ,pp. : 192-201

Karger

Access to resources Recommend Favorite